Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:list
|
| gptkbp:alsoKnownAs |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:basisFor |
national essential medicines lists
|
| gptkbp:contains |
essential medicines
|
| gptkbp:criteria |
public health relevance
comparative cost-effectiveness evidence on efficacy and safety |
| gptkbp:firstPublished |
1977
|
| https://www.w3.org/2000/01/rdf-schema#label |
WHO essential medicine
|
| gptkbp:includes |
gptkb:insulin
antibiotics vaccines antivirals antihypertensives anesthetics antimalarials antituberculosis medicines cancer medicines pain medications |
| gptkbp:latestReleaseVersion |
23rd edition (2023)
|
| gptkbp:maintainedBy |
gptkb:World_Health_Organization
|
| gptkbp:purpose |
identify most effective and safe medicines for health systems
|
| gptkbp:separateListFor |
adults
children |
| gptkbp:updated |
every two years
|
| gptkbp:usedBy |
countries worldwide
|
| gptkbp:website |
https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines
|
| gptkbp:bfsParent |
gptkb:didanosine
gptkb:Naltrexone gptkb:abacavir gptkb:ritonavir gptkb:artemisinin gptkb:hydroxyurea |
| gptkbp:bfsLayer |
6
|